ResMed Reports 10% Revenue Growth, Sees Wearables and GLP-1s Driving Future Demand
CEO sees “once-in-a-generation” opportunities in sleep-tracking wearables and GLP-1 therapies to drive patient flow.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
